Vimarsana
Biggest News Aggregation in the World

Page 2 - Cellular Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Therapy Today - Breaking & Trending Today

CSPAN Washington Journal December 16, 2015 - Vimarsana News

CSPAN Washington Journal December 16, 2015

Dialing in. The candidates talked terror last night. Thats the headline over las vegas. That was the topic after the paris attacks and the San Bernardino shootings. If you look at some of the early voting states, well start with the des moines register, where they have the caucus, the headline out of iowa, republicans in that state say trump slips, rubio shines. A little bit from jennifer acobs piece this morning host it said bush repeatedly feuded with trump, and at the same time drove home that National Security is his wheelhouse, the iowans said. Take a look at the he can changes between th...

Teclistamab Triplet Shows Manageable Safety, Early Efficacy in Transplant-Ineligible Myeloma - Vimarsana News

Teclistamab Triplet Shows Manageable Safety, Early Efficacy in Transplant-Ineligible Myeloma

Teclistamab plus daratumumab and lenalidomide had a manageable safety profile in patients with transplant-ineligible, newly diagnosed multiple myeloma.

Data for Quadruplet Therapies Could Alter Frontline SOC for Transplant-Ineligible Multiple Myeloma - Vimarsana News

Data for Quadruplet Therapies Could Alter Frontline SOC for Transplant-Ineligible Multiple Myeloma

Muhamed Baljevic, MD, FACP, discusses the investigation of frontline quadruplet therapies in transplant-ineligible multiple myeloma.

First-Line Quadruplet Regimens Continue to Enhance Outcomes in Myeloma - Vimarsana News

First-Line Quadruplet Regimens Continue to Enhance Outcomes in Myeloma

Muhamed Baljevic, MD, FACP, discusses the evolution of quadruplet combination therapies in frontline multiple myeloma.

Dr Baljevic on Key Considerations for Treatment Selection in Newly Diagnosed Multiple Myeloma - Vimarsana News

Dr Baljevic on Key Considerations for Treatment Selection in Newly Diagnosed Multiple Myeloma

Muhamed Baljevic, MD, discusses the consideration of patient comorbidities and preferences during treatment selection in newly diagnosed myeloma.